Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Etiena Basner-Tschakarjan

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The American Journal of Pathology|August 1, 2006
Rapid growth of invasive metastatic melanoma in carcinogen-treated hepatocyte growth factor/scatter factor-transgenic mice carrying an oncogenic CDK4 mutationDamia Tormo, Aleix Ferrer, Evelyn Gaffal, et al.
Blood|June 10, 2009
AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cellsFederico Mingozzi, Janneke J Meulenberg, Daniel J Hui, et al.
Blood|July 5, 2007
Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liverFederico Mingozzi, Nicole C Hasbrouck, Etiena Basner-Tschakarjan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 30, 2016
Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 CapsidKoen Vercauteren, Brad E Hoffman, Irene Zolotukhin, et al.
The Journal of Clinical Investigation|May 14, 2009
Capsid antigen presentation flags human hepatocytes for destruction after transduction by adeno-associated viral vectorsGary C Pien, Etiena Basner-Tschakarjan, Daniel J Hui, et al.
Blood|January 18, 2013
Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cellsAshley T Martino, Etiena Basner-Tschakarjan, David M Markusic, et al.
Blood|May 5, 2017
Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8<sup>+</sup> T cellsGeoffrey L Rogers, Jamie L Shirley, Irene Zolotukhin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 29, 2010
Safety of AAV factor IX peripheral transvenular gene delivery to muscle in hemophilia B dogsVirginia Haurigot, Federico Mingozzi, George Buchlis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 17, 2013
Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopesDaniel J Hui, Etiena Basner-Tschakarjan, Yifeng Chen, et al.
Plos One|May 14, 2013
AAV-mediated gene therapy for choroideremia: preclinical studies in personalized modelsVidyullatha Vasireddy, Jason A Mills, Rajashekhar Gaddameedi, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The American Journal of Pathology|August 1, 2006
Rapid growth of invasive metastatic melanoma in carcinogen-treated hepatocyte growth factor/scatter factor-transgenic mice carrying an oncogenic CDK4 mutationDamia Tormo, Aleix Ferrer, Evelyn Gaffal, et al.
Blood|June 10, 2009
AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cellsFederico Mingozzi, Janneke J Meulenberg, Daniel J Hui, et al.
Blood|July 5, 2007
Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liverFederico Mingozzi, Nicole C Hasbrouck, Etiena Basner-Tschakarjan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 30, 2016
Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 CapsidKoen Vercauteren, Brad E Hoffman, Irene Zolotukhin, et al.
The Journal of Clinical Investigation|May 14, 2009
Capsid antigen presentation flags human hepatocytes for destruction after transduction by adeno-associated viral vectorsGary C Pien, Etiena Basner-Tschakarjan, Daniel J Hui, et al.
Blood|January 18, 2013
Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cellsAshley T Martino, Etiena Basner-Tschakarjan, David M Markusic, et al.
Blood|May 5, 2017
Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8<sup>+</sup> T cellsGeoffrey L Rogers, Jamie L Shirley, Irene Zolotukhin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 29, 2010
Safety of AAV factor IX peripheral transvenular gene delivery to muscle in hemophilia B dogsVirginia Haurigot, Federico Mingozzi, George Buchlis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 17, 2013
Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopesDaniel J Hui, Etiena Basner-Tschakarjan, Yifeng Chen, et al.
Plos One|May 14, 2013
AAV-mediated gene therapy for choroideremia: preclinical studies in personalized modelsVidyullatha Vasireddy, Jason A Mills, Rajashekhar Gaddameedi, et al.
Pageof 3